ArticlePLOS digital health2025
Deep neural network modeling for brain tumor classification using magnetic resonance spectroscopic imaging.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study is driven by the complex and specialized nature of magnetic resonance spectroscopy imaging (MRSI) data processing, particularly within the scope of brain tumor assessments. Traditional methods often involve intricate manual procedures that demand considerable expertise. In response, we investigate the application of deep neural networks directly to raw MRSI data in the time domain. Given the significant health risks associated with brain tumors, the necessity for early and accurate detection is crucial for effective treatment. While conventional MRI techniques encounter limitations in the rapid and precise spatial evaluation of diffuse gliomas, both accuracy and efficiency are often compromised. MRSI presents a promising alternative by providing detailed insights into tissue chemical composition and metabolic changes. Our proposed model, which utilizes deep neural networks, is specifically designed for the analysis and classification of spectral time series data. Trained on a dataset that includes both synthetic and real MRSI data from brain tumor patients, the model aims to distinguish MRSI voxels that indicate pathological conditions from healthy ones. Our findings demonstrate the model's robustness in classifying glioma-related MRSI voxels from those of healthy tissue, achieving an area under the receiver operating characteristic curve of 0.95. Overall, these results highlight the potential of deep learning approaches to harness raw MR data for clinical applications, signaling a transformative impact on diagnostic and prognostic assessments in brain tumor examinations. Ongoing research is focused on validating these approaches across larger datasets, to establish standardized guidelines and enhance their clinical utility.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.